Publication
IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.
Authors not recorded
Blood2018PMID 30282799PMC6251006stubpubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CIVIC-20260908-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Data not yet available
No abstract stored. Read on PubMed
Linked entities
Linked entities (2)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 2
- geneMYCcivic_curation1.00
- variantMYC Fusioncivic_curation1.00
Curated evidence
Evidence citing this paper (1)
civicProvenance
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 30282799
- Run
- ING-CIVIC-20260908-000001
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| MYC Fusion1 | ||||||||
| (diagnostic) | B-lymphoblastic Leukemia With MYC RearrangementUNRESOLVED | Diagnostic | B | Supports Positive | 3 | accepted | EID12381In this 2018 study, the authors analyzed tumor samples from 13 patients diagnosed with IG-MYC–positive neoplasms exhibiting a precursor B-cell phenotype. This entity is molecularly distinct from class… (full text at CIViC) PMID 30282799 · Wagener et al., 2018 · Open in CIViC | civic |